A new bipartisan bill aims to speed rare disease drug development by making clinical trials faster, cheaper and more ...

Incyte (Nasdaq:INCY) and Genmab A/S (Nasdaq:GMAB) today announced a clinical trial collaboration to evaluate INCB161734, ...

The Institute for Healthcare Improvement (IHI), in partnership with Bristol Myers Squibb (BMS), is launching a new Cancer ...

AI may expand access to clinical trials for rural patients by overcoming geographic barriers and limited research ...

MsFLASH, an NIH-funded menopause clinical trials network active from 2008 to 2022, ran 5 trials with 9 interventions and 8 ...

New Report puts the market at $66.3bn in 2025, with oncology accounting for 38.3% and North America just over half, though patchy insurer coverage and infrastructural barriers remain stubborn ...

A clinical trial is a research study involving a select group of people — either healthy individuals or patients dealing with a disease — who have volunteered to try a new intervention under close ...

Genialis Supermodel shows how biology-first AI can extract meaningful insights from limited patient data, across clinical ...

Identify strategic trial locations to save time and cost, uncover business opportunities, guide investments and benchmark enrollment trends, success rates and competitors.Dublin, Oct. 23, 2026 (GLOBE ...

The overview summarizes available evidence on the investigational molecule, including reported Phase 2 and Phase 3 clinical trial results, while emphasizing the need for continued safety evaluation ...

Genmab A/S(Nasdaq: GMAB) andIncyte(Nasdaq: INCY) today announced a clinical trial collaboration to evaluate petosemtamab, ...